Adaptive Biotechnologies Corp

General ticker "ADPT" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $904.1M

Adaptive Biotechnologies Corp follows the US Stock Market performance with the rate: 48.1%.

Estimated limits based on current volatility of 5.0%: low 5.91$, high 6.53$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.31$, 7.72$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.35$, 7.72$]

Financial Metrics affecting the ADPT estimates:

  • Negative: Non-GAAP EPS, $ of -1.38 <= 0.10
  • Negative: Operating profit margin, % of -57.14 <= 1.03
  • Negative: Operating cash flow per share per price, % of -18.66 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term ADPT quotes

Long-term ADPT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $154.34MM $185.31MM $170.28MM
Operating Expenses $363.31MM $385.49MM $397.31MM
Operating Income $-208.97MM $-200.19MM $-227.03MM
Non-Operating Income $1.67MM $-0.18MM $1.73MM
Interest Expense $0.00MM $4.24MM $13.80MM
R&D Expense $142.34MM $141.76MM $122.12MM
Income(Loss) $-207.30MM $-200.37MM $-225.30MM
Taxes $0.00MM $0.00MM $-0.05MM
Profit(Loss) $-207.30MM $-200.37MM $-225.25MM
Stockholders Equity $603.99MM $464.17MM $308.40MM
Inventory $19.26MM $14.45MM $14.45MM
Assets $923.34MM $856.62MM $661.13MM
Operating Cash Flow $-192.73MM $-183.94MM $-156.32MM
Capital expenditure $61.75MM $16.35MM $10.70MM
Investing Cash Flow $181.21MM $2.90MM $129.65MM
Financing Cash Flow $27.15MM $132.26MM $2.25MM
Earnings Per Share* $-1.46 $-1.00 $-1.56

* EPS are Split Adjusted, recent splits may be reflected with a delay.